As supply chains become increasingly partner-dependent, organizations are reevaluating how they collaborate with CMOs to improve agility, visibility, scalability, and operational performance. Moving beyond traditional transactional models, leading companies are building more integrated, strategic partnerships that enable stronger alignment across planning, manufacturing, quality, data sharing, and risk management. In this keynote discussion, Bristol Myers Squibb will explore the evolving role of CMOs within today's pharmaceutical supply chain ecosystem and share insights into what it takes to build more connected, resilient, and collaborative external manufacturing networks capable of supporting increasingly complex therapies and global operations.

• Explore how pharmaceutical organizations are evolving CMO relationships from transactional outsourcing models to more strategic, integrated partnerships
• Understand the operational, quality, and communication challenges that can create friction across external manufacturing networks, and how to proactively address them
• Learn strategies for improving visibility, alignment, and collaboration across planning, manufacturing, quality, and supply chain teams to drive stronger end-to-end performance